Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 13;4(5):445-9.
doi: 10.1111/jdi.12070. Epub 2013 Apr 11.

Kir6.2 E23K polymorphism is related to secondary failure of sulfonylureas in non-obese patients with type 2 diabetes

Yoshinori Shimajiri  1 , Akiko Yamana  1 , Shuhei Morita  1 , Hiroto Furuta  2 , Machi Furuta  1 , Tokio Sanke  3
Affiliations

Kir6.2 E23K polymorphism is related to secondary failure of sulfonylureas in non-obese patients with type 2 diabetes

Yoshinori Shimajiri et al. J Diabetes Investig. .

Abstract

Aims/introduction: The Kir6.2 E23K polymorphism was studied with a special reference to secondary sulfonylurea (SU) failure in non-obese patients with type 2 diabetes.

Materials and methods: We recruited 278 non-obese (body mass index ≤30.0 kg/m(2)) Japanese patients with type 2 diabetes who had a history of SU treatment (for 11.2 ± 6.3 years) and compared the frequency of the secondary SU failure among the genotypes of the polymorphism. Genotyping of the Kir6.2 E23K was carried out by polymerase chain reaction-restriction fragment length polymorphism.

Results: The genotype frequencies of the polymorphism were similar to those previously reported in Japanese patients with type 2 diabetes. The frequency with which patients deteriorated into secondary SU failure was significantly higher in those with the KK genotype than those with EE or EK genotypes. Among 214 patients who eventually received insulin therapy because of secondary SU failure, the period of SU treatment in those with the KK genotype was significantly shorter than those with the EE or EK genotype, although the period from diagnosis to the start of SU treatment was not significantly different.

Conclusions: These data suggest that the Kir6.2 E23K polymorphism is related to the acceleration of secondary SU failure in non-obese Japanese patients with type 2 diabetes.

Keywords: Kir6.2 E23K polymorphism; Secondary failure of sulfonylurea; Type 2 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analysis of therapeutic changes (standard treatment to secondary sulfonylurea [SU]) in the Kir6.2 E23K variants in patients with type 2 diabetes evaluated by the Kaplan–Meier method. The KK and the other (EE or EK) genotype carriers are shown as a thick solid line and dotted line, respectively.
Figure 2
Figure 2
Analysis of therapeutic changes (sulfonylurea [SU] to insulin) in the Kir6.2 E23K variants in patients with type 2 diabetes evaluated by the Kaplan–Meier method. The KK and the other (EE or EK) genotype carriers are shown as a thick solid line and dotted line, respectively.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Aguilar‐Bryan L, Nicholas CG, Wechsler SW, et al Cloning of the β cell high‐affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995; 268: 423–426 - PubMed
    1. Inagaki N, Gonoi T, Clement JP, et al Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270: 1166–1170 - PubMed
    1. Seino S, Inagaki N, Namba N, et al Molecular biology of the β‐cell ATP‐sensitive K+ channel. Diabetes Rev 1996; 4: 177–190
    1. Koster JC, Marshall BA, Ensor N, et al Targeted overactivity of β cell KATP channels induces profound neonatal diabetes. Cell 2000; 100: 645–654 - PubMed
    1. Gloyn AL, Pearson ER, Antcliff JF, et al Activating mutations in the gene encoding the ATP‐sensitive potassium‐channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 1838–1849 - PubMed